Cargando…
Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
BACKGROUND: This research provides the first evidence of CDK5 in ccRCC prognosis and correlation with different p21 expression in overall survival (OS) analysis. METHODS: The data from both of The Cancer Genome Atlas (TCGA) and Gene Expression of Normal and Tumor Tissue (GENT) were analyzed for dete...
Autores principales: | Zhu, Liangsong, Ding, Rong, Zhang, Jianping, Zhang, Jin, Lin, Zongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636025/ https://www.ncbi.nlm.nih.gov/pubmed/31311512 http://dx.doi.org/10.1186/s12885-019-5905-9 |
Ejemplares similares
-
ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2020) -
Correction: ZHX2 drives cell growth and migration via activating MEK/ERK signal and induces Sunitinib resistance by regulating the autophagy in clear cell Renal Cell Carcinoma
por: Zhu, Liangsong, et al.
Publicado: (2021) -
AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019) -
Synthetic lethality of cyclin-dependent kinase inhibitor Dinaciclib with VHL-deficiency allows for selective targeting of clear cell renal cell carcinoma
por: Nelson, Luke J, et al.
Publicado: (2022) -
TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma
por: Pan, Qiufeng, et al.
Publicado: (2020)